KTTA Logo

Pasithea Therapeutics Corp. (KTTA) 

NASDAQ
Market Cap
$3.33M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
743 of 960
Rank in Industry
413 of 550

Largest Insider Buys in Sector

KTTA Stock Price History Chart

KTTA Stock Performance

About Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Insider Activity of Pasithea Therapeutics Corp.

Over the last 12 months, insiders at Pasithea Therapeutics Corp. have bought $0 and sold $0 worth of Pasithea Therapeutics Corp. stock.

On average, over the past 5 years, insiders at Pasithea Therapeutics Corp. have bought $377,671 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 30,000 shares for transaction amount of $12,930 was made by STEINMAN LAWRENCE (director) on 2023‑06‑02.

List of Insider Buy and Sell Transactions, Pasithea Therapeutics Corp.

2023-06-02Purchasedirector
30,000
0.124%
$0.43$12,930-5.00%
2022-10-17Purchasedirector
1,000
0.004%
$1.11$1,110-53.15%
2022-09-29PurchaseMember of 10% owner group
6,710
0.0248%
$1.16$7,757-50.85%
2022-09-28Purchase
6,710
0.0243%
$1.16$7,757-51.42%
2022-09-28PurchaseMember of 10% owner group
57,647
0.2151%
$1.19$68,542-51.42%
2022-09-06PurchaseMember of 10% owner group
21,748
0.0814%
$1.13$24,632-47.37%
2022-09-02PurchaseMember of 10% owner group
11,507
0.0429%
$1.14$13,105-47.87%
2022-09-01PurchaseMember of 10% owner group
55,646
0.2051%
$1.13$62,630-47.83%
2022-09-01Purchase
55,646
0.2051%
$1.13$62,630-47.83%
2022-08-30PurchaseMember of 10% owner group
17,828
0.0658%
$1.15$20,452-48.72%
2022-08-29Purchase
17,828
0.065%
$1.15$20,452-49.37%
2022-08-29PurchaseMember of 10% owner group
5,000
0.0186%
$1.17$5,841-49.37%
2022-08-19Purchase
54,644
0.2002%
$1.30$70,939-55.06%
2022-08-17PurchaseMember of 10% owner group
155,773
0.5629%
$1.21$188,283-52.38%
2022-08-17Purchase
155,773
0.5629%
$1.21$188,283-52.38%

Insider Historical Profitability

<0.0001%
Shahinian EricMember of 10% owner group
1788415
141.2174%
$2.6380<0.0001%
Camac Partners, LLC
1788415
141.2174%
$2.6340<0.0001%
STEINMAN LAWRENCEdirector
1327174
104.7967%
$2.6310<0.0001%
Delaney Daviddirector
227521
17.9656%
$2.6310<0.0001%
Leonite Capital LLC
54644
4.3148%
$2.6310<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.